Patient guide · Reviewed May 2026
FibroScan vs Alternatives — Which Liver Test Is Right for You?
FibroScan is not the only way to assess liver health. Several alternative non-invasive tests are available in Australia, each with different strengths, limitations, and appropriate uses. Understanding the options helps patients and GPs choose the most appropriate test for their specific situation.
This guide compares FibroScan to the main alternatives available in Australia.
Published 2026-05-31 · Clinically reviewed 2026-05-31
Patient guide · Reviewed May 2026
The Comparison at a Glance
| Test | Fibrosis | Fat | Radiation | Referral Needed | Cost (AUD) | Availability |
|---|---|---|---|---|---|---|
| FibroScan (blind VCTE) | ✓ kPa | ✓ CAP | None | Often not | $150–$300 | Wide |
| Guided elastography (2D shear wave) | ✓ kPa | ✓ UAP | None | Often not | $150–$300 | Growing |
| 2D Shear Wave Elastography | ✓ kPa | Partial | None | Yes | $200–$400 | Specialist centres |
| MRI elastography | ✓ kPa | ✓ PDFF | None | Yes | $500–$900 | Limited |
| CT scan | Partial | Partial | Yes | Yes | $200–$500 | Wide |
| Liver biopsy | ✓ Definitive | ✓ | Minor | Yes | $1,500–$3,000+ | Hospital/day procedure |
FibroScan (Vibration-Controlled Transient Elastography)
The most widely used liver elastography device in Australia. Echosens FibroScan uses blind probe placement — the operator positions the probe by feel without real-time imaging guidance — and measures liver stiffness (kPa) and fat content (CAP score).
Best for: Standard MASLD assessment in patients with normal to moderately elevated BMI. Well-validated, widely available, no radiation, no referral required at many Australian clinics.
Limitations: Accuracy decreases at higher BMI; requires probe switching between M and XL probes; blind placement increases operator variability; no real-time imaging to confirm probe position. See /patientcare/fibroscan-limitations for full detail.
Patient guide · Reviewed May 2026
Guided Elastography (2D Shear Wave Systems)
Guided elastography adds real-time B-mode ultrasound imaging to the transient elastography workflow — the operator sees the liver on screen and positions the…
Guided elastography adds real-time B-mode ultrasound imaging to the transient elastography workflow — the operator sees the liver on screen and positions the probe under visual guidance before taking measurements.
Best for: Patients with higher BMI where FibroScan accuracy is reduced; clinics wanting improved reproducibility; point-of-care assessment where both imaging and stiffness measurement are needed in one session.
Advantages over FibroScan: Single universal probe for all patient types; real-time imaging confirms correct positioning; reduced operator variability; simultaneous B-mode imaging provides anatomical context alongside stiffness measurement.
Available at: A growing number of Australian gastroenterology, hepatology, and imaging centres. Use the clinic directory on this site to find providers near you.
2D Shear Wave Elastography (2D-SWE)
2D-SWE is available on high-end ultrasound machines from manufacturers including SuperSonic Imagine (Aixplorer) and GE Healthcare. It uses a different mechanical wave approach to measure liver stiffness, providing a colour-coded elasticity map of the liver alongside a quantitative kPa measurement.
Best for: Specialist hepatology centres that already have 2D-SWE-capable ultrasound equipment; research settings; patients where a broader liver anatomical assessment is needed alongside stiffness measurement.
Limitations: Requires specialist equipment not universally available; results differ from FibroScan reference ranges (different kPa thresholds apply); less widely validated in all liver disease subgroups compared to transient elastography.
Patient guide · Reviewed May 2026
MRI Elastography (MRE)
MRI elastography uses magnetic resonance imaging to measure liver stiffness across the entire liver volume — providing the most comprehensive non-invasive…
MRI elastography uses magnetic resonance imaging to measure liver stiffness across the entire liver volume — providing the most comprehensive non-invasive fibrosis assessment available. MRI also allows simultaneous measurement of liver fat content using proton density fat fraction (PDFF), which is more precise than CAP scoring.
Best for: Complex cases where FibroScan or 2D-SWE results are inconclusive; patients with cirrhosis where precise fibrosis mapping affects surgical or treatment planning; research settings.
Limitations: Expensive ($500–$900+); limited availability at Australian specialist centres; requires MRI-compatible patients (no ferromagnetic implants); longer appointment time; requires referral.
CT Scan
Standard abdominal CT can detect significant hepatic steatosis (liver appears darker than normal) but cannot measure liver fibrosis — the most important prognostic factor in MASLD. CT also involves radiation exposure making it unsuitable for routine or repeated liver monitoring.
Best for: Excluding other liver pathology (tumours, vascular disease, complications of cirrhosis). Not recommended as the primary test for MASLD staging.
Not recommended for: Routine fatty liver assessment, fibrosis staging, or treatment monitoring. See /fatty-liver-scan-vs-ct for detailed comparison.
Patient guide · Reviewed May 2026
Liver Biopsy
Liver biopsy remains the diagnostic gold standard — the only test that can definitively stage fibrosis and confirm MASH histologically. A needle is inserted…
Liver biopsy remains the diagnostic gold standard — the only test that can definitively stage fibrosis and confirm MASH histologically. A needle is inserted through the skin under local anaesthetic to remove a small core of liver tissue for laboratory analysis.
Best for: Cases where non-invasive tests are inconclusive and management decisions require certainty; diagnosing MASH definitively; clinical trial enrolment requiring biopsy-confirmed diagnosis.
Limitations: Invasive with a small but real risk of serious complications (bleeding, infection — approximately 1 in 1,000 significant adverse events); hospital or day procedure admission required; sampling error (the needle samples only 1/50,000th of the liver); expensive; subject to interobserver variability in pathology reporting.
For most patients with MASLD, non-invasive testing with FibroScan or guided elastography provides sufficient information for clinical management without the need for biopsy.
Which Test Is Right for You?
Standard assessment, normal BMI: FibroScan at a clinic near you.
Higher BMI, previous unreliable FibroScan: Guided elastography with universal probe, or repeat FibroScan with XL probe.
Inconclusive FibroScan, complex clinical picture: 2D-SWE at a specialist centre or MRI elastography.
Monitoring treatment response (including GLP-1 medications): FibroScan or guided elastography — same device type each time for serial comparison.
Excluding liver tumours or complications: CT or MRI — but this is not the primary test for MASLD staging.
Find a liver elastography clinic near you
Search by suburb or postcode to see accredited clinics offering FibroScan and guided liver elastography across Australia.
Type a suburb or postcode and press Enter to search nearby.
Request a liver scan appointment
Submit your details and we'll route your request to the most appropriate elastography clinic in your area. Most clinics respond within 1–2 business days.
Take action
Request an appointment
Frequently asked questions
Is guided elastography better than FibroScan?
Guided elastography and FibroScan use the same underlying technology. The key difference is real-time imaging guidance, which can improve accuracy in difficult patients — particularly those with higher BMI — and reduce operator variability. For standard patients, both perform comparably. For complex patients or clinics wanting the most reproducible results, guided elastography offers advantages.
Which test does Medicare cover?
Currently, liver elastography — FibroScan or guided alternatives — does not have a Medicare item number for most MASLD indications. Liver biopsy, CT, and MRI may attract rebates depending on indication. This is actively being reviewed in the context of the 2025 Australian MASLD guidelines.
Can I choose which test I have?
You can request a specific test but availability depends on your clinic. Discuss with your GP which test is most appropriate for your situation — and whether the nearest clinic has the equipment you need.
This article is for educational purposes only. It does not constitute medical advice. Always consult your GP or a specialist about your individual health circumstances.
Next step
Find a liver elastography clinic near you
Search participating clinics across Australia, or submit an appointment request and we will route you to the nearest available provider.